Sarcopedia

MalignantSoft tissue

Ectomesenchymoma

Synonyms: Malignant Ectomesenchymoma (MEM), Gangliorhabdomyosarcoma

Mixed neural and rhabdomyoblastic tumour

Quick Facts

Behaviour

Malignant

Category

Soft tissue

Grade

High

Synonyms

  • Malignant Ectomesenchymoma (MEM)
  • Gangliorhabdomyosarcoma

Category

Soft tissue

Behaviour

Malignant

Grade

High

Gender

Male (1.5:1)

Tissue of Origin

Neural crest

Epidemiology

  • Extremely rare (less than 100 cases reported)
  • Children and adolescents most commonly affected

Clinical Features

  • Rapidly enlarging soft tissue mass
  • Aggressive clinical behaviour

Location

  • Head and neck
  • Abdomen
  • Perineum

Imaging

MRI: large heterogeneous mass, areas of necrosis or haemorrhage. Low T1 and high T2 signal with vivid enhancement

Pathology

Biphasic appearance: Nests of small round blue cells interspersed with ganglion cells or primitive neuroectodermal cells

Genetics

Highly variable; can involve DICER1 mutations or translocations associated with rhabdomyosarcoma

Treatment

  • Multiagent chemotherapy (rhabdomyosarcoma protocols)
  • Wide surgical resection
  • Radiotherapy

Prognosis

  • Poor - 5-year survival 25-40%
  • Limited data due to rarity

Key Points

  • Mixed neural and rhabdomyoblastic tumour
  • Children most affected
  • Treated like high-grade rhabdomyosarcoma

Workup - Blood Tests

  • FBC, U&E, LFTs
  • LDH - prognostic marker

Workup - Local Imaging

MRI with contrast of primary site

Workup - Biopsy

  • Core needle biopsy
  • Extensive IHC panel

Workup - Staging

  • CT chest
  • PET-CT
  • May require bone marrow aspirate

Follow-up Summary

Medical disclaimer

The content on Sarcopedia is for educational and informational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical diagnosis or treatment. Always consult with a qualified physician regarding any health concerns or before starting any new treatment. Reliance on any information provided on this site is solely at your own risk.